Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation

Hematology Journal

Volumn 4, Issue 6, 2003, Pages 436-440

  Velati, Claudio ^a   Marlianici, Eugenia ^a   Rigamonti, Danila ^a   Barillari, Giovanni ^b   Chiavilli, Francesco ^c   Fugiani, Paolo ^d   Garozzo, Giovanni ^e   Lancieri, Mario ^f   Rinaldi, Sandro ^g   Testa, Domenico ^h   Sampietro, Maurizio ⁱ   Tavazzi, Dario ⁱ   Delbini, Paola ⁱ   Fargion, Silvia ⁱ   Fiorelli, Gemino ⁱ  

^a Ospedale Civile di Sondrio   (Italy)

^b Ospedale di Udine   (Italy)

^c Ospedale Civ Medio Polesine Rovigo   (Italy)

^d Ospedale Civile E Profili Fabriano   (Italy)

^e Civile MP Arezzo Hospital   (Italy)

^f DI VENERE HOSPITAL   (Italy)

^g Ospedale San Maurizio   (Italy)

^h Ospedale di Savigliano   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

Author keywords

Hemochromatosis; HFE; Iron; Transfusion

Indexed keywords

FERRITIN; HFE PROTEIN; TRANSFERRIN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD OXYGEN TENSION; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEMATOLOGICAL PARAMETERS; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON OVERLOAD; ITALY; MAJOR CLINICAL STUDY; MALE; SCREENING TEST; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; ADULT; BLOOD DONORS; FEMALE; FERRITINS; GEOGRAPHY; HEMOCHROMATOSIS; HETEROZYGOTE DETECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; ITALY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; REFERENCE VALUES; TRANSFERRIN;

EID: 9144227435     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200324     Document Type: Article

References (18)

1. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, (eds). Iron Metabolism in Health and Disease. Saunders: London. 1994, pp 227-270.
2. Powell LW. Hemochromatosis: the impact of early diagnosis and therapy. Gastroenterology 1996; 110: 1304-1307.
3. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998; 129: 925-931.
4. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
5. The UK Hemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with hemochromatosis. Gut 1997; 41: 841-844.
6. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-832.
7. Borot N, Roth MP, Malfroy L, Demangel C, Vinel JP, Pascal JP et al. Mutation in the MHC class I-like candidate gene for hemochromatosis. Immunogenetics 1997; 45: 320-324.
8. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998; 114: 996-1002.
9. Sanchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 1998; 29: 725-728.
10. Velati C, Piperno A, Fargion S, Colombo S, Fiorelli G. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors. Haematologica 1990; 75: 309-312.
11. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-278.
12. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk K. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002; 122: 646-651.
13. Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GB, Blanc F et al. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001; 48: 836-842.
14. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997; 61: 762-764.
15. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000; 133: 329-337.
16. Åsberg A, Hveem K, Thorstensen E, Ellekjaer E, Kannelønning K, Fjøsne U et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65238 persons. Scand J Gastroenterol 2001; 10: 1108-1115.
17. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD et al. HFE mutations, iron deficiency and overload in 10500 blood donors. Br J Haematol 2001; 114: 474-484.
18. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996; 245: 139-200.